AXS-14 (Esreboxetine)
AXS-14-FM-301
Phase 3 small_molecule active
Quick answer
AXS-14 (Esreboxetine) for Fibromyalgia is a Phase 3 program (small_molecule) at Axsome Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Axsome Therapeutics
- Indication
- Fibromyalgia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active